Pantoprazole Mepha

Pantoprazole, the active ingredient in Pantoprazole Mepha, is a proton pump inhibitor presented as a tablet for gastroenteral use. It treats acid‑related disorders such as gastroesophageal reflux disease, erosive esophagitis, and peptic ulcer disease in adults.

GNH USA supplies Pantoprazole Mepha as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazole acts on the gastric proton pump to reduce acid secretion, making it useful for several acid‑related conditions. - Gastroesophageal reflux disease (GERD): reduces esophageal irritation by lowering gastric acid exposure. - Erosive esophagitis: promotes healing of inflamed esophageal mucosa through sustained acid suppression. - Peptic ulcer disease: facilitates ulcer closure and symptom relief by maintaining a less acidic gastric environment.

Pantoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: loose stools that may be self‑limiting. - Abdominal pain: discomfort in the stomach region. - Nausea: feeling of queasiness. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Clostridioides difficile infection: severe colitis associated with antibiotic use. - Hypomagnesemia: low magnesium levels with prolonged therapy. - Elevated liver enzymes: signs of hepatic stress. - Stevens‑Johnson syndrome: rare severe skin reaction. - Pancreatitis: inflammation of the pancreas.

Before initiating therapy, consider the following precautions. - Assess renal function: adjust use in severe impairment. - Monitor magnesium levels: prolonged treatment may cause hypomagnesemia. - Review concomitant CYP2C19 inhibitors: may require dose adjustment. - Use caution in hepatic impairment: consider dose modification. - Pregnancy and lactation: safety not established; prescribe only if benefit outweighs risk. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Pantoprazole may interact with several medicines; monitoring is advised.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect. - Atazanavir: decreased antiviral exposure. - Methotrexate: increased toxicity.

Moderate Interactions (Monitor Closely): - Digoxin: possible increase in serum concentration. - Warfarin: potential INR elevation.